SCHEMBL17487137

SCHEMBL17487137

Cc1ccc(C#N)c(-c2c3cc4c(cc3c(-c3cc(C)ccc3C#N)c3c5cc6ccccc6c6cccc(c23)c65)c2cccc3c5ccccc5cc4c32)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 1/20 0.35
DYRK1A Q13627 1/20 0.35
ALDH1A1 P00352 4/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
HIF1A Q16665 1/20 0.33
GRM2 Q14416 1/20 0.33
CYP1A2 P05177 4/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
PDE9A O76083 1/20 0.32
KDM4E B2RXH2 3/20 0.31
GAA P10253 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
MAPT P10636 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17487142 1.00 CLK1 (0.35) CLK1DYRK1AALDH1A1HPGDHSD17B10
SCHEMBL17487140 0.86 ALDH1A1 (0.41) CLK1DYRK1AALDH1A1HPGDHSD17B10
SCHEMBL17487136 0.86 ALDH1A1 (0.41) CLK1DYRK1AALDH1A1HPGDHSD17B10
SCHEMBL22824161 0.83 ALDH1A1 (0.35) CLK1DYRK1AALDH1A1HPGDHSD17B10
SCHEMBL22823939 0.83 ALDH1A1 (0.40) CLK1DYRK1AALDH1A1HPGDHSD17B10
SCHEMBL22824163 0.82 ALDH1A1 (0.34) CLK1DYRK1AALDH1A1HPGDHSD17B10
SCHEMBL22824058 0.81 ALDH1A1 (0.32) CLK1DYRK1AALDH1A1HPGDHSD17B10
SCHEMBL22824059 0.81 ALDH1A1 (0.31) CLK1DYRK1AALDH1A1HPGDHSD17B10
SCHEMBL17487146 0.79 CA1 (0.39) ALDH1A1HPGDHSD17B10L3MBTL1TSHR
SCHEMBL17487145 0.79 CA1 (0.39) ALDH1A1HPGDHSD17B10L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9472766-B2 Fused polycyclic compound and organic light emitting element including the same CANON KABUSHIKI KAISHA (JP) 2016-10-18 US disclosed
US-9472766-B2 Fused polycyclic compound and organic light emitting element including the same CANON KABUSHIKI KAISHA (JP) 2016-10-18 US disclosed
US-20160035982-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2016-02-04 US disclosed
US-20160035982-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160035982-A1 NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME NR2E3, PUF60, CRY2 CLK1 1822/4885DYRK1A 4514/4885ALDH1A1 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.